Related Experiment Videos
Reimmunization after blood or marrow stem cell transplantation
1Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock 72205, USA.
Bone Marrow Transplantation
|April 28, 1999
Summary
Immunity wanes after blood and marrow transplants, necessitating timely reimmunization. Guidelines are proposed for post-transplant vaccination strategies to restore protective immunity.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Protective immunity declines post-blood and marrow transplantation (BMT).
- Immunity transfer from donors is insufficient to maintain protection.
- Re-establishing immunity through vaccination is crucial.
Purpose of the Study:
- To review current data on post-transplant vaccination.
- To propose guidelines for reimmunization protocols after BMT.
Main Methods:
- Comprehensive literature review of published studies on post-transplant vaccination.
- Analysis of factors influencing vaccine response in transplant recipients.
Main Results:
- Vaccine response varies based on transplant type, cell source, patient immune status, and vaccine type.
- Inactivated/subunit vaccines are safe; live vaccines are generally contraindicated.
- Current reimmunization practices differ significantly across transplant centers.
Conclusions:
- Systematic reimmunization is essential following BMT to restore protective immunity.
- Proposed guidelines can serve as a framework for developing standardized reimmunization protocols.
- Further research may refine vaccination strategies in diverse transplant populations.